Uranus Chemicals Co. Ltd.

As of June 30, 2026, Uranus Chemicals Co. Ltd. carries a market capitalization of 9.23B, placing it among publicly traded companies globally. Its enterprise value stands at 10.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Uranus Chemicals Co. Ltd. has 66.38M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Uranus Chemicals Co. Ltd. maintains a current ratio of 1.39, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Uranus Chemicals Co. Ltd.'s stock has gained approximately 210.56% over the past 52 weeks. The 50-day moving average sits at 109.42, while the 200-day moving average is 109.45.

As of June 30, 2026, Uranus Chemicals Co. Ltd. holds 665.55M in cash and equivalents against 1.47B in total debt, resulting in a net debt position of 768.51M. Total book value stands at 1.74B, with working capital of 537.72M providing operational flexibility.